11 results on '"Victor M Lu"'
Search Results
2. The composition of landmark vein of Galen malformation research: the emergence of endovascular treatments
- Author
-
Victor M. Lu, Evan M. Luther, Michael A. Silva, Shivani D. Rangwala, Robert M. Starke, Edward R. Smith, and Alfred P. See
- Subjects
Pediatrics, Perinatology and Child Health ,Neurology (clinical) ,General Medicine - Published
- 2022
- Full Text
- View/download PDF
3. Global, regional, and national epidemiological trends in neural tube defects between 1990 and 2019: a summary
- Author
-
Victor M. Lu
- Subjects
Pediatrics, Perinatology and Child Health ,Neurology (clinical) ,General Medicine - Published
- 2023
- Full Text
- View/download PDF
4. Clinical complications of surviving gunshot wounds to the head in children and adolescents: the Miami experience
- Author
-
Victor M. Lu, Evan Kreuger, Joacir G. Cordeiro, Toba N. Niazi, Jonathan R. Jagid, and Heather J. McCrea
- Subjects
Pediatrics, Perinatology and Child Health ,Neurology (clinical) ,General Medicine - Published
- 2022
- Full Text
- View/download PDF
5. National characteristics, etiology, and inpatient outcomes of pediatric traumatic brain injury: a KID study
- Author
-
Victor M. Lu, Nicole Hernandez, and Shelly Wang
- Subjects
Male ,Inpatients ,Databases, Factual ,Infant ,General Medicine ,Length of Stay ,Patient Discharge ,Hospitalization ,Brain Injuries, Traumatic ,Pediatrics, Perinatology and Child Health ,Humans ,Female ,Neurology (clinical) ,Child - Abstract
Traumatic brain injury (TBI) in pediatric patients is a major burden to public health. Understanding clinical associations with severity and short hospitalization (≤ 1 day length of stay) is needed to better inform management paradigms and optimize triage.A retrospective review of the Kids' Inpatient Database (KID) was performed for all data reported between 2006 and 2012 for TBI patients aged ≤ 20 years. Univariate and multivariate regression analyses were performed to identify predictive factors of trauma severity and short hospitalization.A total of 220,777 pediatric TBI cases were identified, with the majority of cases being boys (66%) with a mean age of 11.5 years. Mean length of stay was 5.0 days, with 25% discharged within 1 day, and 83% routinely discharged home. In-hospital mortality occurred in 4% of cases. More severe TBI presentations were significantly and independently associated with older age, weekend admissions, hospital transfers, and in patients with chronic conditions and neurological issues (all P 0.01). There were 38% of admission that were short hospitalizations. Younger age, male gender, less chronic conditions, fall and assault etiologies, and with milder injury severity all significantly and independently predicted greater likelihood of short hospitalization.The severity of pediatric TBI admissions to the hospital can be impacted by a number of parameters. Furthermore, there exists a subset of clinical associations for short hospitalization admissions. Proactive identification of these parameters at time of presentation will assist in optimizing the management of pediatric TBI].
- Published
- 2022
- Full Text
- View/download PDF
6. Distinct survival and clinical profile of infantile glioblastoma: insights from a national database
- Author
-
Evan Luther, Ossama M. Maher, Ashish H. Shah, Victor M. Lu, Daniel G Eichberg, Toba N. Niazi, and David J. Daniels
- Subjects
Oncology ,Chemotherapy ,medicine.medical_specialty ,business.industry ,Proportional hazards model ,medicine.medical_treatment ,Cancer ,General Medicine ,medicine.disease ,Comorbidity ,Radiation therapy ,Statistical significance ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Neurology (clinical) ,Neurosurgery ,business ,Glioblastoma - Abstract
BACKGROUND The diagnosis of glioblastoma (GBM) in infants aged ≤ 1 year is extremely rare, and its comparability to the more common adult diagnosis is underexplored. Correspondingly, the objective of this study was to interrogate a national cancer database to elucidate the typical survival and clinical profile of this demographic. METHODS All GBM patients aged ≤ 1 year in the U.S. National Cancer Database (NCDB) between 2005 and 2016 were retrospectively reviewed. Data were summarized, and overall survival (OS) was modeled using Kaplan-Meier and Cox regression analyses. RESULTS A total of 86 patients satisfied criteria for entry into study, making up 0.08% of all GBM diagnoses in the database. There were 32 (37%) females and 54 (63%) males. Irrespective of treatment, median OS was 67.3 months (95% CI, 46-91), which was distinct from all other ages and pediatric age groups. There were 74 (86%) treated by surgery, 51 (59%) treated by chemotherapy, and 17 (20%) treated by radiation therapy. Multivariable analysis demonstrated that Hispanic status (HR = 3.41, P = 0.02) and the presence of comorbidity (HR = 3.24, P = 0.01) independently predicted shorter OS, whereas treatment with chemotherapy (HR = 0.18, P
- Published
- 2021
- Full Text
- View/download PDF
7. Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: a database study
- Author
-
Victor M. Lu, Ossama M. Maher, Daniel G Eichberg, Evan Luther, David J. Daniels, Toba N. Niazi, Long Di, and Ashish H. Shah
- Subjects
medicine.medical_specialty ,Chemotherapy ,Multivariate analysis ,Proportional hazards model ,business.industry ,medicine.medical_treatment ,Cancer ,General Medicine ,medicine.disease ,Radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Atypical teratoid rhabdoid tumor ,medicine ,Neurology (clinical) ,Neurosurgery ,Medical diagnosis ,business ,030217 neurology & neurosurgery - Abstract
Atypical teratoid/rhabdoid tumor (ATRT) is a rare and largely pediatric diagnosis, with poor survival. Diagnosis below the age of 3 years is characteristically seen as a poor prognostic sign. However, elucidating if clinical differences exist within this niche age group has never been attempted before. Correspondingly, we sought to characterize clinical profile of ATRT diagnoses before the age of 3 years based on separate ages of diagnosis. All pediatric ATRT patients aged < 3 years in the US National Cancer Database (NCDB) between 2005 and 2016 were retrospectively reviewed. Age groups were divided based on diagnoses at ages 0–1 years in group 1, 1–2 years in group 2, and 2–3 years in group 3. Data were summarized, and overall survival (OS) was modeled using Kaplan–Meier and Cox regression analyses. A total of 354 ATRT diagnoses were made before the age of 3 years, with surgery used in 316 (89%) cases, chemotherapy in 242 (68%) cases, and radiation therapy in 118 (33%) cases. In terms of diagnosis age, there were 153 (43%) in group 1, 137 (39%) in group 2, and 64 (18%) in group 3. With respect to OS, median value was 9.9 months in group 1, 28.4 months in group 2, and 15.9 months in group 3. Upon multivariate analysis, receiving radiation therapy was the only parameter shared amongst all three groups as independently prognostic of longer OS (HR 0.53, P = 0.01 in group 1; HR 0.34, P < 0.01 in group 2; HR 0.31, P < 0.01 in group 3). In group 1, surgery (HR 0.47, P < 0.01) and chemotherapy (HR 0.44, P < 0.01) were also independently prognostic of longer OS. In group 3, multiple socioeconomic parameters were identified to independently predict longer OS. There were no additional predictive parameters identified in group 2. Although ATRT diagnosed before the age of 3 is typically viewed a poor prognostic age category, our findings demonstrate that the clinical profile of this pediatric niche is highly heterogeneous based on age of diagnosis. Survival of only those diagnosed between 0 and 1 years is independently prognosticated by all three treatment modalities; patients diagnosed between 1 and 2 years trend towards longest survival, and socioeconomic parameters are most influential in those diagnosed between 2 and 3 years.
- Published
- 2020
- Full Text
- View/download PDF
8. Understanding the trajectory of research efforts in atypical teratoid rhabdoid tumors: a bibliometric analysis of the 50 most impactful studies to date
- Author
-
Victor M. Lu, David J. Daniels, and Ruby G. Siada
- Subjects
0301 basic medicine ,Bibliometric analysis ,business.industry ,Rhabdoid tumors ,Scopus ,General Medicine ,Disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Medicine ,Observational study ,Neurology (clinical) ,business ,Citation ,Genetic composition ,Demography ,Cohort study - Abstract
Atypical teratoid/rhabdoid tumor (ATRT) is a highly malignant embryonal tumor of the central nervous system (CNS) that occurs predominantly in children. More is being discovered about this disease to improve understanding and outcomes. The aim of this analysis was to evaluate citation and other bibliometric characteristics of the 50 most cited articles in the contemporary literature in order to better model the trajectory of our current efforts. Elsevier’s Scopus database was searched for the 50 most cited articles about ATRT. To look for trends, earliest 25 articles were separated from the latest 25 articles and then were compared. Various bibliometric parameters were summarized and compared using Pearson’s chi-square and Mann–Whitney U tests. The 50 most cited articles were published between 1990 and 2016, from 5 unique countries in 29 unique journals, with genetic and retrospective observational cohort studies the most common design (n = 11 each). Overall median values were as follows: citation count, 145.4 citations (range, 67–626); citation rate per year, 11.7 (range, 3.5–51.4); number of authors 12 (range, 1–95); with 32 (64%) originating from the USA. Compared with older articles, newer articles had statistically lower citation counts (101.8 vs 189.0; P < 0.01), higher number of authors (17.3 vs 6.6; P < 0.01), and were less likely published from the USA (40% vs 88%; P < 0.01) The 50 most cited articles about ATRT were characterized in this analysis. There was a distinct focus in these studies on the genetic composition and consequences of these tumors. Trends over time suggest greater impact will be had in highly collaborative efforts worldwide. Moving forward, it will be of great interest to see how the findings of these basic science finding will translate into future clinical studies.
- Published
- 2020
- Full Text
- View/download PDF
9. Recurring pediatric anaplastic ependymoma with rare peritoneal carcinomatosis: a case report and hypothesis of mechanism
- Author
-
Victor M. Lu, David J. Daniels, Ruby G. Siada, and Jonathan Schwartz
- Subjects
medicine.medical_specialty ,business.industry ,Widespread Disease ,General Medicine ,Ventricular system ,030218 nuclear medicine & medical imaging ,Peritoneal carcinomatosis ,body regions ,Anaplastic Ependymoma ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Peritoneum ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Recurrent disease ,medicine ,Neurology (clinical) ,Neurosurgery ,Radiology ,business ,Surgical interventions - Abstract
Although recurrent anaplastic ependymoma in pediatric patients is not uncommon, recurrent disease leading to widespread metastases to the peritoneum is extremely rare. We present a case of an 18-month old male who initially presented with posterior fossa anaplastic ependymoma, who then proceeded to present 1 year later with spinal recurrence, and then 2 years after that with widespread disease involving the intracranial ventricular system and peritoneum. We posit that surgical interventions to treat primary and recurrent presentations in combination with a conduit to the peritoneum via a ventriculoperitoneal shunt contributed to the mechanisms of this complex case.
- Published
- 2020
- Full Text
- View/download PDF
10. The 100 most-cited articles about diffuse intrinsic pontine glioma: a bibliometric analysis
- Author
-
David J. Daniels, Erica A Power, Victor M. Lu, and Panogiotis Kerezoudis
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Bibliometric analysis ,business.industry ,Diffuse Intrinsic Pontine Glioma ,Scopus ,General Medicine ,03 medical and health sciences ,Clinical prognosis ,030104 developmental biology ,0302 clinical medicine ,Bibliometrics ,030220 oncology & carcinogenesis ,Citation rate ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Brain Stem Neoplasms ,Humans ,Medicine ,Neurology (clinical) ,Citation ,business - Abstract
Although the dismal clinical prognosis of diffuse intrinsic pontine glioma (DIPG) has not changed, there has been significant progress in the academic literature made in the biological understanding of this brainstem tumor. The aim of this analysis was to evaluate citation and other bibliometric characteristics of the 100 most-cited DIPG articles in the current literature in order to better understand the current state of our academic efforts in this area. Elsevier’s Scopus database was searched for the 100 most-cited articles that focussed on DIPG. Articles were dichotomized as either primarily basic science (BSc) or clinical (CL) articles. Various bibliometric parameters were summarized and comparison between BSc and CL articles was performed using Pearson’s chi-square and Mann–Whitney U tests. Of the 100 most-cited articles, 36 (36%) were BSc and 64 (64%) were CL articles. Overall median values were as follows: citation count, 52 (range, 27–261); citation rate per year, 8.6 (range, 1.7–104); number of authors, 9 (range, 1–63); and publication year, 2011 (range, 1997–2017). Articles were published in a total of 43 different journals and predominately originated in the USA (n = 67, 67%). When compared with CL articles, BSc articles reported significantly greater citation count (P = 0.03), citations rate per year (P
- Published
- 2019
- Full Text
- View/download PDF
11. Endoscopic versus open approach in craniosynostosis repair: a systematic review and meta-analysis of perioperative outcomes
- Author
-
Victor M. Lu, Anshit Goyal, Yagiz U. Yolcu, Mohamed Elminawy, and David J. Daniels
- Subjects
medicine.medical_specialty ,Craniosynostosis ,Craniosynostoses ,03 medical and health sciences ,0302 clinical medicine ,Blood loss ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Prospective Studies ,Retrospective Studies ,business.industry ,General surgery ,030206 dentistry ,General Medicine ,Perioperative ,Plastic Surgery Procedures ,medicine.disease ,Observational Studies as Topic ,Treatment Outcome ,Systematic review ,Meta-analysis ,Neuroendoscopy ,Pediatrics, Perinatology and Child Health ,Cohort ,Operative time ,Neurology (clinical) ,Neurosurgery ,business ,Craniotomy ,030217 neurology & neurosurgery - Abstract
Surgery for craniosynostosis remains a crucial element in successful management. Intervention by both endoscopic and open approaches has been proven effective. Given the differences in timing and indications for these procedures, differences in perioperative outcomes have yet to be thoroughly compared between the two approaches. The aim of the systematic review and meta-analysis was to assess the available evidence of perioperative outcomes between the two approaches in order to better influence the management paradigm of craniosynostosis. We followed recommended PRISMA guidelines for systematic reviews. Seven electronic databases were searched to identify all potentially relevant studies published from inception to February 2018 which were then screened against a set of selection criteria. Data were extracted and analyzed using meta-analysis of proportions. Twelve studies satisfied all the selection criteria to be included, which described a pooled cohort involving 2064 craniosynostosis patients, with 965 (47%) and 1099 (53%) patients undergoing surgery by endoscopic and open approaches respectively. When compared to the open approach, it was found that the endoscopic approach conferred statistically significant reductions in blood loss (MD = 162.4 mL), operative time (MD = 112.38 min), length of stay (MD = 2.56 days), and rates of perioperative complications (OR = 0.58), reoperation (OR = 0.37) and transfusion (OR = 0.09), where all p
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.